From Nasdaq: 2025-01-31 08:59:00

Healthcare companies have reported fourth-quarter 2024 earnings, showing growth drivers in patient volumes, utilization, and rate hikes. While rising medical costs offset some gains, stocks like AMGN, COR, HUM, and ARDT are set to beat earnings estimates. The medical sector is projected to see 12.5% earnings growth and 8.6% revenue rise.

Patient volumes increased in Q4 due to more visits and surgeries, boosting revenue per admission. Rising medical costs were offset by premium rate hikes and demand for commercial healthcare plans. Technological innovations like AI improved clinical workflows, reducing costs. Companies like Cencora, Amgen, Humana, and Ardent Health show potential earnings beats.

Cencora’s Q1 earnings are expected to benefit from GLP-1 drug sales, while Amgen’s Q4 results may improve from product sales growth. Humana’s strong premium growth and growing memberships are positive factors. Ardent Health’s rising admissions position it for a better Q4. These companies have an Earnings ESP and Zacks Rank to potentially surpass expectations.

Zacks’ Research Chief highlights a stock with the potential to double in value. This innovative financial firm with a fast-growing customer base and cutting-edge solutions could see significant gains. Stocks like Nano-X Imaging have seen impressive growth. For the latest stock recommendations, download the free report from Zacks Investment Research.



Read more at Nasdaq:: 4 Healthcare Stocks Poised to Crush Q4 Earnings Estimates